Reports Q4 revenue $53.45B, consensus $52.72B. “Fiscal 2023 was an inflection point for Cardinal Health, with improved performance, strong execution and notable progress against both our short and long-term plans,” said Jason Hollar, CEO of Cardinal Health. “We are pleased with the strong finish to the year, including robust cash flow generation, continued strong growth in the Pharmaceutical segment and significant improvement in the Medical segment, driven by execution of our Medical Improvement Plan. We enter the new fiscal year with momentum and are raising our previously communicated fiscal year 2024 EPS guidance.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CAH:
- Cardinal Health (NYSE:CAH) Stock Down Despite Positive Q4 Results
- Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2023 at High End of Investor Day Guidance
- Notable companies reporting before tomorrow’s open
- CAH Upcoming Earnings Report: What to Expect?
- Cardinal Health Board of Directors Approves Quarterly Dividend